Erythema nodosum triggered by BNT162b2 mRNA COVID-19 vaccine

被引：2

作者：

Juddoo, Vanessa ^{[1
]}

Juddoo, Sonia ^{[2
]}

Megarbane, Bruno ^{[3
]}

机构：

[1] Lariboisiere Hosp, Dept Endocrinol & Diabetol, Paris, France

[2] Avicenne Hosp, Dept Geriatr, Bobigny, France

[3] Paris Univ, Lariboisiere Hosp, Dept Med & Toxicol Crit Care, INSERM,UMRS 1144, Paris, France

来源：

VACCINE | 2022年 / 40卷 / 19期

关键词：

POLYMORPHISM;

D O I：

10.1016/j.vaccine.2022.03.052

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：2650 / 2651

页数：2

共 6 条

[1]

Amoli MM, 2008, CLIN EXP RHEUMATOL, V26, pS155

[2]

Amoli MM, 2011, CLIN EXP RHEUMATOL, V29, pS131

[3] Combined reduced-antigen content tetanus, diphtheria, and acellular pertussis (Tdap) vaccine- related erythema nodosum: Case report and review of vaccine-associated erythema nodosum [J].

Cohen P.R. .

Dermatology and Therapy, 2013, 3 (2) :191-197

[4] Cutaneous Manifestations in Confirmed COVID-19 Patients: A Systematic Review [J].

Conforti, Claudio ;

Dianzani, Caterina ;

Agozzino, Marina ;

Giuffrida, Roberta ;

Marangi, Giovanni Francesco ;

di Meo, Nicola ;

Morariu, Silviu-Horia ;

Persichetti, Paolo ;

Segreto, Francesco ;

Zalaudek, Iris ;

Neagu, Nicoleta .

BIOLOGY-BASEL, 2020, 9 (12) :1-28

[5]

Hali F, 2021, World J Vaccines, V11, P33, DOI DOI 10.4236/WJV.2021.113005

[6] Causality assessment in pharmacovigilance: The French method and its successive updates [J].

Miremont-Salame, Ghada ;

Theophile, Helelne ;

Haramburu, Francoise ;

Begaud, Bernard .

THERAPIE, 2016, 71 (02) :179-186

← 1 →